Evidence map›Paper›PMID 41583378›Full record

ArticleEndoscopic ultrasound

Double-blind randomized noninferiority study of the effect of pharyngeal lidocaine anesthesia on EUS.

Yuki Fujii, Kazuyuki Matsumoto, Kei Harada, Nao Hattori, Ryosuke Sato, Taisuke Obata, Akihiro Matsumi, Kazuya Miyamoto, Daisuke Uchida, Shigeru Horiguchi and 3 more

Abstract read
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuki FujiiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.ORCID https://orcid.org/0000-0002-4231-9955
Kazuyuki MatsumotoDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.ORCID https://orcid.org/0000-0002-5102-7452
Kei HaradaDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Nao HattoriDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Ryosuke SatoDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Taisuke ObataDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Akihiro MatsumiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Kazuya MiyamotoDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Daisuke UchidaDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Shigeru HoriguchiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Koichiro TsutsumiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Toshiharu MitsuhashiCenter for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Motoyuki OtsukaDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives: EUS is typically performed under sedation, often with concomitant analgesics to reduce pain. Traditionally used pharyngeal anesthesia, commonly with lidocaine, may cause pharyngeal discomfort and allergic reactions. This study investigated whether lidocaine-based pharyngeal anesthesia is necessary for EUS under sedation with analgesics. Methods: A double-blind, randomized, noninferiority study was conducted on EUS cases that met the selection criteria. Patients were randomly assigned to receive either 5 sprays of 8% lidocaine (lidocaine group: LG) or saline spray (placebo group: PG) as endoscopy pretreatment. The primary outcome was EUS tolerability, analyzed separately for endoscopists and patients, with a noninferiority margin set at 15%. Secondary outcomes included endoscopist and patient satisfaction, midazolam/pethidine doses, number of gag events, number of esophageal insertion attempts, use of sedative/analgesic antagonists, interruptions due to body movements, throat symptoms after endoscopy, and sedation-related adverse events. Results: Favorable tolerance was 85% in LG and 88% for PG among endoscopists (percent difference: 3.0 [95% confidence interval, -6.6 to 12.6]) and 90% in LG and 91% in PG among patients (percent difference, 0.94 [95% confidence interval, -7.5 to 9.4]). Both groups exceeded the noninferiority margin ( Conclusions: PG was noninferior to LG for pharyngeal anesthesia during EUS with sedation and analgesics. These results suggest that pharyngeal anesthesia with lidocaine can be omitted when performing EUS under sedation with concomitant analgesics. Omitting pharyngeal anesthesia with lidocaine may prevent discomfort and complications caused by pharyngeal anesthesia, shorten examination times, and reduce medical costs.

Indexed as

EUSLidocaineTolerance

Identifiers

PMID41583378
PMCPMC12829627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.